Chemical pneumonitis is caused by inhaling toxic and/or irritant substances, most commonly large volumes of sterile gastric contents, into the lungs that results in a noninfectious inflammatory reaction from chemical damage to the airways and lung parenchyma. Aspiration pneumonia is a bacterial infection of the lungs caused by macroaspiration (large volume aspiration) of colonized oropharyngeal or upper gastrointestinal contents. Symptoms include cough and dyspnea. Diagnosis is based on clinical presentation and chest radiographic findings. Treatment and prognosis differ depending on the substance that was aspirated and whether an infection is present.
Aspiration can cause lung inflammation (chemical pneumonitis), infection (bacterial pneumonia or lung abscess), or airway obstruction (because the presence of undigested food particles causes mechanical obstruction or reflex airway spasm). Microaspiration of small quantities of upper airway secretions is common even in healthy individuals; however, this aspirated material is cleared by normal lung immune defense mechanisms. The term aspiration pneumonia is used when the ability to protect the lower airway is compromised and/or a large volume is aspirated. Drowning may also cause inflammation of the lungs.
Aspiration pneumonia may account for 5 to 15% of all community acquired pneumonia (1). For example, one large multicenter observational study, found that 7.4% of cases of community-acquired pneumonia in hospitalized patients were aspiration-related (2). Importantly, many aspiration episodes are unwitnessed.
Risk factors for aspiration include:
Impaired level of consciousness (eg, due to medication or illicit drug overdose, alcohol intoxication, seizures)
Dysphagia (due to esophageal and/or laryngeal disorders, neurologic diseases)
Vomiting
Gastrointestinal devices and procedures (eg, nasogastric tube placement)
Laryngeal dysfunction (eg, vocal fold paralysis)
Respiratory devices and procedures (eg, endotracheal tube placement—see Ventilator-Associated Pneumonia)
Oral dysbiosis (eg, due to periodontal disease such as gingivitis)
Dental procedures
General references
1. Mandell LA, Niederman MS. Aspiration Pneumonia. N Engl J Med. 2019;380(7):651-663. doi:10.1056/NEJMra1714562
2. Marin-Corral J, Pascual-Guardia S, Amati F, et al. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2021;159(1):58-72. doi:10.1016/j.chest.2020.06.079
Pathophysiology of Chemical Pneumonitis and Aspiration Pneumonia
Chemical pneumonitis
Multiple substances are directly toxic to the lungs or stimulate an inflammatory response when aspirated; gastric acid is the most common such aspirated substance. Others include petroleum products (particularly of low viscosity, such as petroleum jelly) and laxative oils (eg, mineral oil, castor oil, paraffin oil). Petroleum products and laxative oils can cause lipoid pneumonia, which is a noninfectious, chemically induced pneumonitis. Aspirated gasoline and kerosene can also cause a chemical pneumonitis (see Hydrocarbon Poisoning).
Gastric contents cause damage mainly due to gastric acid, although food and other ingested material (eg, activated charcoal as in treatment of overdose) are injurious in quantity. Gastric acid causes a sterile, inflammatory injury from the direct caustic effect of low-pH fluid on lung tissue; subsequently, a chemical "burn" of the airways and lungs develops, followed by acute inflammation (ie, neutrophil response, release of inflammatory mediators, surfactant inactivation) (1). This inflammatory response leads to rapid bronchoconstriction, atelectasis, and edema.
Chemical pneumonitis may resolve spontaneously, usually within a few days, or may progress to acute respiratory distress syndrome. Although chemical pneumonitis is typically initially sterile, bacterial superinfection can develop as a complication in about a quarter of patients (2).
Aspiration pneumonia
Aspiration pneumonia shares the same pathophysiology as other bacterial pneumonias (eg, impaired host defense, aspiration, bacterial virulence); however, macroaspiration of larger volumes of colonized material is the predominant mechanism of pathogen delivery, particularly in the context of predisposing risk factors.
Healthy people commonly microaspirate oral secretions, but normal host immune defense mechanisms usually clear the inoculum without sequelae. Aspiration of larger amounts, or aspiration in a patient with impaired pulmonary defenses, often causes pneumonia and/or a lung abscess (3). Older patients tend to aspirate because of conditions associated with aging that alter consciousness (eg, sedative use) and other disorders (eg, neurologic disorders, swallowing disorders). Empyema (see Pleural Effusion) also occasionally complicates aspiration (4).
The microbiology of aspiration pneumonia largely mirrors that of the clinical setting in which the aspiration occurs. In community-acquired pneumonia, streptococci and other pathogens that typically cause community-acquired pneumonia predominate, while gram-negative bacilli and Staphylococcus aureus are more common in hospital-acquired pneumonia (3). Periodontal disease, by altering oral microbiota and promoting bacterial dysbiosis, may predispose to anaerobic infection.
Pathophysiology references
1. Košutova P, Mikolka P. Aspiration syndromes and associated lung injury: incidence, pathophysiology and management. Physiol Res. 2021;70(Suppl4):S567-S583. doi:10.33549/physiolres.934767
2. Darie AM, Stolz D. Is There a Role for Bronchoscopy in Aspiration Pneumonia?. Semin Respir Crit Care Med. 2024;45(6):650-658. doi:10.1055/s-0044-1791739
3. Mandell LA, Niederman MS. Aspiration Pneumonia. N Engl J Med. 2019;380(7):651-663. doi:10.1056/NEJMra1714562
4. McCauley L, Dean N. Pneumonia and empyema: causal, casual or unknown. J Thorac Dis. 2015;7(6):992-998. doi:10.3978/j.issn.2072-1439.2015.04.36
Symptoms and Signs of Chemical Pneumonitis and Aspiration Pneumonia
Symptoms and signs include:
Cough
Fever
Dyspnea
Chest discomfort
Chemical pneumonitis caused by gastric contents is characterized by a rapid or even abrupt onset (eg, over minutes to hours) and leads to acute dyspnea with cough that is sometimes productive of pink frothy sputum, tachypnea, tachycardia, fever, diffuse or localized crackles, and wheezing. Signs of ongoing aspiration may include frequent throat clearing or a wet-sounding cough after eating. When oil or petroleum jelly is aspirated, pneumonitis may be asymptomatic and detected incidentally on chest radiography or may manifest with low-grade fever, gradual weight loss, and crackles.
Aspiration pneumonia can have a variable onset depending on the underlying etiology. It typically develops over hours to a few days, and in cases caused by anaerobes, the evolution can be subacute. A high-grade fever is more suggestive of aspiration pneumonia rather than chemical pneumonitis. In addition, aspiration pneumonia is typically progressive whereas aspiration pneumonitis can resolve spontaneously over 24 to 48 hours.
Diagnosis of Chemical Pneumonitis and Aspiration Pneumonia
Chest imaging
Sometimes, swallowing studies (eg, barium esophagogram)
The diagnosis of chemical pneumonitis or aspiration pneumonia relies on clinical assessment (combining witnessed or suspected aspiration events), the presence of predisposing risk factors, and compatible chest imaging findings. Chemical pneumonitis and pneumonia are indistinguishable by imaging. For both chemical pneumonitis and aspiration pneumonia, chest radiographs show an infiltrate, frequently but not exclusively, in the dependent lung segments, ie, the superior or posterior basal segments of a lower lobe or the posterior segment of an upper lobe. For aspiration-related lung abscesses, chest radiographs may show a cavitary lesion. Contrast-enhanced computed tomography (CT) is more sensitive and specific for aspiration pneumonia and lung abscess (especially when necrotic tissue is present) (1). In lung abscesses, contrast-enhanced CT will show a round lesion filled with fluid or with an air-fluid level.
In patients with oil or petroleum jelly aspiration, chest radiograph findings vary; consolidation, cavitation, interstitial or nodular infiltrates, pleural effusion, and other changes may be slowly progressive. A CT scan can show fat attenuation within the consolidative opacities and nodules.
Not all episodes of aspiration are witnessed by caregivers or clinicians, therefore, a diagnosis suggested by direct observation is not always possible. Sometimes no signs may be present, and ongoing aspiration is only diagnosed via modified barium esophagography done to exclude an underlying swallowing disorder.
Diagnosis reference
1. Expert Panel on Thoracic Imaging, Batra K, Walker CM, et al. ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompetent Patients: 2024 Update. J Am Coll Radiol. 2025;22(5S):S14-S35. doi:10.1016/j.jacr.2025.02.014
Treatment of Chemical Pneumonitis and Aspiration Pneumonia
Supportive treatment for chemical pneumonitis and aspiration pneumonia
Antibiotics for patients with aspiration pneumonia
Chemical pneumonitis
Treatment of chemical pneumonitis is supportive, often involving supplemental oxygen and, if needed, mechanical ventilation.
Systemic glucocorticoids are not routinely recommended for chemical pneumonitis due to a lack of established clinical efficacy and a heightened risk of complications (1). Anecdotal evidence suggests that glucocorticoids may be beneficial in patients with lipoid pneumonia (2) or in cases that progress to acute respiratory distress syndrome (ARDS) (3), however, the quality of evidence is low.
Empiric antibiotic therapy has not been shown to offer clear evidence of clinical benefit (ie, need for transfer to critical care, reduced mortality) in patients with pneumonitis (4). A preferred approach is close observation with antibiotics being prescribed if the clinical course suggests subsequent bacterial superinfection. Early empiric antibiotics can also be stopped if patients improve rapidly.
Aspiration pneumonia
Antibiotics are usually prescribed for the treatment of aspiration pneumonia (5). Supportive care (eg, supplemental oxygen) may be required in some patients.
For community-acquired aspiration pneumonia, a beta-lactam/beta-lactamase inhibitor (eg, amoxicillin/clavulanic acid, ampicillin/sulbactam) is recommended; moxifloxacin or clindamycin is reserved for use in patients who are allergic to penicillin (6).
For hospital-acquired aspiration pneumonia, a carbapenem or piperacillin/tazobactam can be used, particularly in the context of recent hospitalization and/or parenteral antibiotic use within 90 days (6). If additional risk factors for MRSA are present (eg, prior respiratory isolation of MRSA, treatment in units where > 10 to 20% of S. aureus isolates are methicillin-resistant, recent hospitalization with parenteral antibiotics) medications effective against MRSA (eg, vancomycin, linezolid) are added if risk factors for that pathogen are present.
The duration of antibiotic therapy for community- and hospital-acquired aspiration pneumonia is typically 5 to 7 days; however, high quality data supporting this duration are lacking (5). Longer durations may be required if there is extrapulmonary infection, or if aspiration is complicated by necrotizing pneumonia, lung abscess, or empyema.
Complications of aspiration
Treatment of lung abscess is with antibiotics and sometimes percutaneous or surgical drainage (7). Many clinicians continue antibiotic treatment until the chest radiograph shows complete resolution or only a small, stable, residual abnormality.
Treatment references
1. Wolfe JE, Bone RC, Ruth WE. Effects of corticosteroids in the treatment of patients with gastric aspiration. Am J Med. 1977;63(5):719-722. doi:10.1016/0002-9343(77)90157-7
2. Song C, Wang P, Lu Y. Management of exogenous lipoid pneumonia after fuel aspiration: a single-center experience. J Zhejiang Univ Sci B. 2025;26(12):1233-1244. doi:10.1631/jzus.B2500270
3. Zhao JN, Liu Y, Li HC. Corticosteroids in treatment of aspiration-related acute respiratory distress syndrome: results of a retrospective cohort study. BMC Pulm Med. 2016;16:29. doi:10.1186/s12890-016-0194-4
4. Dragan V, Wei Y, Elligsen M, Kiss A, Walker SAN, Leis JA. Prophylactic Antimicrobial Therapy for Acute Aspiration Pneumonitis. Clin Infect Dis. 2018;67(4):513-518. doi:10.1093/cid/ciy120
5. Mandell LA, Niederman MS. Aspiration Pneumonia. N Engl J Med. 2019;380(7):651-663. doi:10.1056/NEJMra1714562
6. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7): e45-e67. doi: 10.1164/rccm.201908-1581ST
7. Lee JH, Hong H, Tamburrini M, Park CM. Percutaneous transthoracic catheter drainage for lung abscess: a systematic review and meta-analysis. Eur Radiol. 2022;32(2):1184-1194. doi:10.1007/s00330-021-08149-5
Prevention of Chemical Pneumonitis and Aspiration Pneumonia
Strategies to prevent aspiration are important to care and overall clinical outcome. For patients with decreased level of consciousness, avoidance of oral feeding and oral medications and elevation of the head of the bed to > 30 degrees may help. Sedating medications should be stopped.
Patients with dysphagia (due to stroke or other neurologic conditions) have long been recommended to follow diets with thick textures to attempt to reduce the risk of aspiration; however, there is little firm evidence that this approach is effective. A speech pathologist may be able to train patients in specific strategies (chin tuck, etc) to reduce the risk of aspiration. For patients with severe dysphagia, a percutaneous gastrostomy is often used, although the evidence is equivocal regarding the risk of aspiration with this strategy because patients can still aspirate oral secretions and may have reflux of gastrostomy tube feedings (1, 2). Post-pyloric feeding (ie, jejunostomy tubes) may be associated with lower rates of pulmonary aspiration (3).
Optimization of oral hygiene and regular care by a dentist may help prevent development of pneumonia or abscess in patients who repeatedly aspirate.
Prevention references
1. Gomes CA Jr, Andriolo RB, Bennett C, et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev. 2015;2015(5):CD008096. doi:10.1002/14651858.CD008096.pub4
2. Gramlich L, Guenter P. Enteral Nutrition in Hospitalized Adults. N Engl J Med. 2025;392(15):1518-1530. doi:10.1056/NEJMra2406954
3. Liu Y, Wang Y, Zhang B, Wang J, Sun L, Xiao Q. Gastric-tube versus post-pyloric feeding in critical patients: a systematic review and meta-analysis of pulmonary aspiration- and nutrition-related outcomes. Eur J Clin Nutr. 2021;75(9):1337-1348. doi:10.1038/s41430-021-00860-2
Key Points
Patients with unexplained chemical pneumonitis and aspiration pneumonia should be evaluated for an underlying swallowing disorder.
Aspiration pneumonia should be treated with antibiotics; treatment of chemical pneumonitis is primarily supportive.
Secondary prevention of aspiration using various measures is a key component of care for affected patients.
Drug Information for the Topic
